MED12 Controls the Response to Multiple Cancer Drugs through Regulation of TGF-β Receptor Signaling
Sidong Huang(The Netherlands Cancer Institute), Michael Hölzel(The Netherlands Cancer Institute), Theo Knijnenburg(The Netherlands Cancer Institute), Andreas Schlicker(The Netherlands Cancer Institute), Paul Roepman(Agendia (Netherlands)), Ultan McDermott(Wellcome Sanger Institute), Mathew J. Garnett(Wellcome Sanger Institute), Wipawadee Grernrum(The Netherlands Cancer Institute), Chong Sun(The Netherlands Cancer Institute), Anirudh Prahallad(The Netherlands Cancer Institute), Floris H. Groenendijk(The Netherlands Cancer Institute), Lorenza Mittempergher(The Netherlands Cancer Institute), Wouter Nijkamp(The Netherlands Cancer Institute), Jacques Neefjes(The Netherlands Cancer Institute), Ramón Salazar(Institut d'Investigació Biomédica de Bellvitge), Peter ten Dijke(Leiden University Medical Center), Hidetaka Uramoto(University of Occupational and Environmental Health Japan), Fumihiro Tanaka(University of Occupational and Environmental Health Japan), Roderick L. Beijersbergen(The Netherlands Cancer Institute), Lodewyk F.A. Wessels(The Netherlands Cancer Institute), René Bernards(The Netherlands Cancer Institute)
Cited by 431Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis